Voices
Luis Felipe Leite da Silva: Evidence and Gaps on Neoadjuvant Immunotherapy in Localized dMMR/MSI-H Gastric and GEJ Cancers
Luis Felipe Leite da Silva/LinkedIn

Luis Felipe Leite da Silva: Evidence and Gaps on Neoadjuvant Immunotherapy in Localized dMMR/MSI-H Gastric and GEJ Cancers

Luis Felipe Leite da Silva, Teaching assistant at Meta-Analysis Academy, shared a post on LinkedIn:

“Available on ESMO Open, you will find a synthesis of the current evidence and gaps regarding neoadjuvant immune checkpoint inhibitors in localized dMMR/MSI-H gastric and GEJ cancers.

This was led by Wallace Klein Schwengber, with the participation of amazing mentors and a great team: Tanios Bekaii-Saab, Christelle De la Fouchardière, Mohamad Bassam Sonbol, Pedro Uson, Isabella Michelon.

It is open access.”

Title: Neoadjuvant immune checkpoint inhibitors for localized dMMR/MSI-H gastric cancer: a meta-analysis

Authors: W.K. Schwengber, R.A. Pereira, L.F. Leite da Silva, M. Tumelero, G. Lenz, I. Michelon, K. Chung, P.L.S. Uson Junior, T. Bekaii-Saab, C. de la Fouchardière, M.B. Sonbol

Read the Full Article.

Luis Felipe Leite da Silva: Evidence and Gaps on Neoadjuvant Immunotherapy in Localized dMMR/MSI-H Gastric and GEJ Cancers

Read more posts featuring Luis Felipe Leite da Silva on OncoDaily.

cancer CHRISTELLE DE LA FOUCHARDIERE G. Lenz Isabella Michelon K. Chung L.F. Leite da Silva Luís Felipe Leite da Silva M. Tumelero Mohamad Bassam Sonbol OncoDaily Oncology Pedro Uson R.A. Pereira Tanios Bekaii-Saab Wallace Klein Schwengber